United States:
Value-Based Health Care: Issues For Pharmaceutical Companies (Video)
09 June 2017
Ropes & Gray LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Michael Lampert, Ropes & Gray health care partner, discusses
issues facing pharmaceutical companies with the move towards
value-based health care models.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).